Scientists use human cerebral organoid to test drug for deadly brain disease

COVID-19 survivor’s guilt a growing issue as reality of loss settles in
9 March 2021
Researchers find stopping smoking is linked to improved mental health
9 March 2021

Scientists use human cerebral organoid to test drug for deadly brain disease

Approximately two years after establishing a human cerebral organoid system to study Creutzfeldt-Jakob disease (CJD), National Institutes of Health researchers have further developed the model to screen drugs for potential CJD treatment. The scientists, from NIH’s National Institute of Allergy and Infectious Diseases (NIAID), describe their work in Scientific Reports.

Comments are closed.